Sight Sciences Share Price (NASDAQ: SGHT)

$4.08

▲

-0.01

(-0.24%)

Last updated on August 21, 2025 at 1:29 AM IST

$₹

Check the interactive Sight Sciences Stock chart to analyse performance

Sight Sciences stock performance

as on August 21, 2025 at 1:29 AM IST

Today's Low:$4.08
Today's High:$4.12
$4.08
0.0%
Downside
Day's Volatility :0.97%
Upside
0.97%
52 Weeks Low:$2.03
52 Weeks High:$7.05
$4.08
50.25%
Downside
52 Weeks Volatility :71.21%
Upside
42.13%

Sight Sciences Stock Returns

Period	Sight Sciences Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	24.39%	1.5%	0.0%
6 Months	47.83%	-7.1%	0.0%
1 Year	-35.95%	-11.4%	0.0%
3 Years	-47.22%	2.9%	-9.6%

Sight Sciences Inc Key Stats

Check Sight Sciences key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$4.09
Open	$4.08
Today's High	$4.12
Today's Low	$4.08
Market Capitalization	$219.4M
Today's Volume	$96.8K
52 Week High	$7.05
52 Week Low	$2.03
Revenue TTM	$76.3M
EBITDA	$-48.1M
Earnings Per Share (EPS)	$-0.96
Profit Margin	-64.23%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-57.1%

Stock Returns calculator for Sight Sciences Stock including INR - Dollar returns

The Sight Sciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Sight Sciences investment value today

Current value as on today

₹70,994

Returns

₹29,006

(-29.01%)

Returns from Sight Sciences Stock

₹32,895 (-32.89%)

Dollar Returns*

₹3,889 (+3.89%)

Indian investors sentiment towards Sight Sciences Stock

-50%

Period: Jul 21, 2025 to Aug 20, 2025. Change in 30 Days versus previous period

Search interest for Sight Sciences Stock from India on INDmoney has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Sight Sciences Inc

Name
Holdings %
Name
Holdings %
Long Focus Capital Management, LLC
6.06%
BlackRock Inc
4.40%
Vanguard Group Inc
3.47%
Prosight Management, LP
1.86%
B Group, Inc
1.60%
Geode Capital Management, LLC
1.54%

Analyst Recommendation on Sight Sciences Stock

Rating

Trend

Buy

50%Buy

50%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Sight Sciences(by analysts ranked 0 to 5 stars)

Sight Sciences Share Price Target

What analysts predicted

Upside of 4.58%

Target:

$4.27

Current:

$4.08

Sight Sciences share price target is $4.27, a slight Upside of 4.58% compared to current price of $4.08 as per analysts' prediction.

Sight Sciences Stock Insights

Price Movement
In the last 6 months, SGHT stock has moved up by 47.8%
Increasing Revenue
Revenue is up for the last 2 quarters, 17.50M → 19.56M (in $), with an average increase of 10.5% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -14.15M → -11.94M (in $), with an average increase of 18.5% per quarter
SGHT vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 32.2% return, outperforming this stock by 65.1%
SGHT vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 146.9% return, outperforming this stock by 195.6%
Price to Sales
ForSGHT every $1 of sales, investors are willing to pay $2.8, whereas for Boston Scientific Corp., the investors are paying $8.5 for every $1 of sales.

Sight Sciences Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$23.3M	↑ 210.07%
Net Income	$-25.9M	↑ 81.03%
Net Profit Margin	-110.8%	↑ 78.97%

	FY20	Y/Y Change
Revenue	$27.6M	↑ 18.38%
Net Income	$-34.7M	↑ 34.11%
Net Profit Margin	-125.52%	↓ 14.72%

	FY21	Y/Y Change
Revenue	$49.0M	↑ 77.12%
Net Income	$-63.0M	↑ 81.48%
Net Profit Margin	-128.61%	↓ 3.09%

	FY22	Y/Y Change
Revenue	$71.3M	↑ 45.7%
Net Income	$-86.2M	↑ 36.98%
Net Profit Margin	-120.9%	↑ 7.71%

	FY23	Y/Y Change
Revenue	$81.1M	↑ 13.63%
Net Income	$-55.5M	↓ 35.59%
Net Profit Margin	-68.53%	↑ 52.37%

	FY24	Y/Y Change
Revenue	$79.9M	↓ 1.47%
Net Income	$-51.5M	↓ 7.27%
Net Profit Margin	-64.49%	↑ 4.04%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$19.3M	↑ 2.74%
Net Income	$-16.3M	↑ 52.15%
Net Profit Margin	-84.43%	↓ 27.41%

	Q2 FY24	Q/Q Change
Revenue	$21.4M	↑ 10.93%
Net Income	$-12.3M	↓ 24.2%
Net Profit Margin	-57.69%	↑ 26.74%

	Q3 FY24	Q/Q Change
Revenue	$20.2M	↓ 5.68%
Net Income	$-11.1M	↓ 10.24%
Net Profit Margin	-54.9%	↑ 2.79%

	Q4 FY24	Q/Q Change
Revenue	$19.1M	↓ 5.37%
Net Income	$-11.8M	↑ 7.05%
Net Profit Margin	-62.11%	↓ 7.21%

	Q1 FY25	Q/Q Change
Revenue	$17.5M	↓ 8.21%
Net Income	$-14.2M	↑ 19.48%
Net Profit Margin	-80.84%	↓ 18.73%

	Q2 FY25	Q/Q Change
Revenue	$19.6M	↑ 11.74%
Net Income	$-11.9M	↓ 15.64%
Net Profit Margin	-61.04%	↑ 19.8%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$16.8M	↑ 223.65%

	FY20	Y/Y Change
Profit	$18.4M	↑ 9.68%

	FY21	Y/Y Change
Profit	$40.3M	↑ 118.9%

	FY22	Y/Y Change
Profit	$59.0M	↑ 46.16%

	FY23	Y/Y Change
Profit	$69.2M	↑ 17.31%

	FY24	Y/Y Change
Profit	$68.3M	↓ 1.29%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$16.5M	↑ 3.11%

	Q2 FY24	Q/Q Change
Profit	$18.3M	↑ 11.37%

	Q3 FY24	Q/Q Change
Profit	$16.9M	↓ 7.84%

	Q4 FY24	Q/Q Change
Profit	$16.6M	↓ 2.05%

	Q1 FY25	Q/Q Change
Profit	$15.1M	↓ 8.86%

	Q2 FY25	Q/Q Change
Profit	$16.6M	↑ 9.89%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-25.0M	↑ 72.69%
Investing Cash Flow	$-672.0K	↑ 17.89%
Financing Cash Flow	$42.7M	↑ 249.62%

	FY20	Y/Y Change
Operating Cash Flow	$-32.2M	↑ 28.71%
Investing Cash Flow	$-953.0K	↑ 41.82%
Financing Cash Flow	$73.4M	↑ 72.04%

	FY21	Y/Y Change
Operating Cash Flow	$-52.5M	↑ 63.3%
Investing Cash Flow	$-813.0K	↓ 14.69%
Financing Cash Flow	$252.5M	↑ 244.04%

	FY22	Y/Y Change
Operating Cash Flow	$-76.0M	↑ 44.59%
Investing Cash Flow	$-970.0K	↑ 19.31%
Financing Cash Flow	$1.2M	↓ 99.51%

	FY23	Y/Y Change
Operating Cash Flow	$-47.2M	↓ 37.89%
Investing Cash Flow	$-791.0K	↓ 18.45%
Financing Cash Flow	$1.1M	↓ 11.54%

	FY24	Y/Y Change
Operating Cash Flow	$-22.4M	↓ 52.63%
Investing Cash Flow	$-385.0K	↓ 51.33%
Financing Cash Flow	$5.0M	↑ 349.64%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-9.8M	↑ 50.93%
Investing Cash Flow	$-117.0K	↓ 55.68%
Financing Cash Flow	$-942.0K	↓ 350.53%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-9.5M	↓ 3.25%
Investing Cash Flow	$-80.0K	↓ 31.62%
Financing Cash Flow	$441.0K	↓ 146.82%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$600.0K	↓ 106.34%
Investing Cash Flow	$-51.0K	↓ 36.25%
Financing Cash Flow	$-162.0K	↓ 136.73%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-3.5M	↓ 676.5%
Investing Cash Flow	$-137.0K	↑ 168.63%
Financing Cash Flow	$5.4M	↓ 3426.54%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-7.5M	↓ 35.0%
Investing Cash Flow	$-210.0K	-
Financing Cash Flow	$485.0K	↑ 2931.25%

Sight Sciences Technicals Summary

Sell

Neutral

Buy

Sight Sciences is currently in a neutral trading position according to technical analysis indicators.

Sight Sciences Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Sight Sciences Inc	14.29%	47.83%	-35.95%	-47.22%	-87.82%
Medtronic Plc	0.22%	2.23%	2.7%	-3.43%	-10.22%
Edwards Lifesciences Corp.	3.13%	5.68%	12.65%	-17.64%	0.31%
Boston Scientific Corp.	-0.04%	-1.54%	31.63%	151.43%	166.41%
Stryker Corporation	0.72%	0.95%	12.97%	83.71%	106.73%
Abbott Laboratories	4.42%	-1.41%	17.87%	22.19%	29.49%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Sight Sciences Inc	NA	NA	NA	-1.02	-0.57	-0.22	NA	1.35
Medtronic Plc	25.51	25.51	2.16	5.46	0.1	0.04	0.03	37.46
Edwards Lifesciences Corp.	33.03	33.03	4.68	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	61.34	61.34	1.79	2.98	0.12	0.05	NA	15.14
Stryker Corporation	50.48	50.48	2.17	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.35	16.35	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Sight Sciences Inc	Buy	$219.4M	-87.82%	NA	-64.23%
Medtronic Plc	Buy	$118.0B	-10.22%	25.51	13.9%
Edwards Lifesciences Corp.	Buy	$46.3B	0.31%	33.03	72.96%
Boston Scientific Corp.	Buy	$152.7B	166.41%	61.34	13.55%
Stryker Corporation	Buy	$145.9B	106.73%	50.48	12.25%
Abbott Laboratories	Buy	$226.7B	29.49%	16.35	32.43%

About Sight Sciences Inc

Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases. The company operates in two segments, Surgical Glaucoma and Dry Eye. Its products include OMNI surgical system, an implant-free, handheld, single-use, therapeutic technology that enables ophthalmic surgeons to perform a comprehensive procedure indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma, as well as for the catheterization and transluminal viscodilation of Schlemm's canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma; and SION surgical instrument, a bladeless manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The company also provides TearCare system, a dry eye device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.

Organization	Sight Sciences
Employees	216
CEO	Mr. Paul Badawi
Industry	Healthcare

Key Management of Sight Sciences Inc

Name	Title
Mr. Paul Badawi	Co-Founder, President, CEO & Director
Dr. David Badawi M.D.	Co-Founder, CTO & Director
Ms. Alison Perry Bauerlein	CFO, Principal Financial & Accounting Officer and Treasurer
Mr. Jeremy B. Hayden J.D.	Chief Legal Officer & Corporate Secretary
Mr. Brenton Taylor	Executive Vice President of Operations
Mr. Steve R. Tamayo Jr.	VP and Chief Ethics & Compliance Officer
Mr. Matthew W. Link	Chief Commercial Officer
Dr. Manohar K. Raheja Ph.D.	Executive Vice President of Research & Development
Mr. Jim Rodberg	VP of Finance & Corporate Controller

Important FAQs about investing in SGHT Stock from India :

What is Sight Sciences share price today?

Sight Sciences share price today is $4.08 as on August 21, 2025 at 1:29 AM IST at the close of the market. Sight Sciences share today touched a day high of $4.12 and a low of $4.08.

What is the 52 week high and 52 week low for Sight Sciences share?

Sight Sciences share touched a 52 week high of $7.05 and a 52 week low of $2.03. Sight Sciences stock price today i.e. August 21, 2025 at 1:29 AM IST is closed at $4.08, lower by 42.13% versus the 52 week high.

How to invest in Sight Sciences Stock (SGHT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Sight Sciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Sight Sciences Shares that will get you 0.3676 shares as per Sight Sciences share price of $4.08 per share as on August 21, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Sight Sciences Stock (SGHT) from India?

Indian investors can start investing in Sight Sciences (SGHT) shares with as little as ₹87.0225 or $1 (as of August 21, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹870.22 in Sight Sciences stock (as per the Rupee-Dollar exchange rate as on August 21, 2025). Based on Sight Sciences share’s latest price of $4.08 as on August 21, 2025 at 1:29 AM IST, you will get 2.4510 shares of Sight Sciences. Learn more about fractional shares .

What are the returns that Sight Sciences has given to Indian investors in the last 5 years?

Sight Sciences stock has given -87.82% share price returns and 16.26% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?